Jeffrey “Jeff” Moore’s research group is dedicated to the professional development of next-generation scientists and educators who will impact the world with their skills and knowledge. The group’s research integrates ideas from physical organic...
David Kranz’s lab been involved for many years in the discovery of immunotherapeutic approaches to cancer. The research program he leads is focused on the structure, function, and engineering of T cell receptors. The Kranz lab is interested in understanding the...
John Katzenellenbogen directs a research program that intersects chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer and androgens in prostate cancer. He explores critical problems in hormone-regulated...
Stephen Sligar has spent his professional career focused on the discovery, development, and use of chemical and biophysical tools to understand fundamental problems in biochemistry. Sligar’s lab developed the Nanodisc platform, which allows for the generation of a...
Lawrence Schook is an international scholar of comparative genomics who has developed the Oncopig Cancer Model, a biomedical cancer model to help medical professionals better understand and treat the disease. The Oncopig Cancer Model (OCM) is a next-generation large...
Edward Roy’s lab is developing immunotherapies for brain tumors that are effective and selective, focused on T cell mediated immune responses. Using animal models, Roy’s lab explores the immune system, and how their murine system closely parallels the human immune...
John Erdman studies how dietary changes, such as the consumption of tomato products, reduces the risk of prostate cancer. Tomatoes or lycopenes are often mentioned as foods or supplements that may have a positive impact on patients with prostate cancer. He evaluates...
